Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.

Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM.

Psychol Med. 2009 Oct;39(10):1607-16. doi: 10.1017/S0033291709005522. Epub 2009 Apr 1.

PMID:
19335936
2.

Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.

Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Farré M, Zuardi AW, McGuire PK.

Curr Pharm Des. 2012;18(32):4966-79. Review.

PMID:
22716148
3.

The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.

van Amsterdam J, Brunt T, van den Brink W.

J Psychopharmacol. 2015 Mar;29(3):254-63. doi: 10.1177/0269881114565142. Epub 2015 Jan 13. Review.

PMID:
25586398
4.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
5.

Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).

Bossong MG, Jansma JM, Bhattacharyya S, Ramsey NF.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:53-69. doi: 10.1016/j.pnpbp.2013.11.017. Epub 2013 Dec 29. Review.

PMID:
24380726
7.

Cannabis in the arm: what can we learn from intravenous cannabinoid studies?

Englund A, Stone JM, Morrison PD.

Curr Pharm Des. 2012;18(32):4906-14. Review.

PMID:
22716141

Supplemental Content

Support Center